Tenax Therapeutics Inc To Discuss the Topline Level Results Transcript
Good day and welcome to the Tenex Therapeutics Phase 3 Level Top-Line Results Conference Call.
All participants will be in a listen-only mode.
Should you need assistance, please signal a conference specialist by pressing the star key followed by 0.
After today's presentation, there will be an opportunity to ask questions.
To ask a question, you may press star then 1 on a touch-tone phone.
To withdraw your question, please press star then 2.
Please note, this event is being recorded.
I would now like to turn the conference over to Chris Giordano, President and Chief Executive Officer. Please go ahead.
Good morning, everyone.
Thank you, Betsy.
Thank you everyone for joining us. I'm Chris Giordano, President and Chief Executive Officer of Tenax Therapeutics.
This morning, we released top-line results from Level, our first phase three trial of oral levosimendin in patients with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
